AdBio Partners is a Paris-based venture capital firm investing in early-stage European life sciences startups.
AdBio Partners is a Paris venture capital firm investing in early-stage life sciences startups across Europe. Formerly Advent France Biotechnology, it combines early-stage investment with entrepreneurial support for academic spinouts and research-driven teams.
The firm works with research institutions and technology transfer offices, leading rounds such as the 2023 seed investment in Anoat Therapeutics, and operates from Paris with an AMF-regulated life sciences mandate.
AdBio Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Follow-on Investments2
Current Portfolio Count1
Top Investment Stages
Series B2 (66.7%)
Seed1 (33.3%)
Stage Mix
Series B 67%
AdBio Partners - Classification
Also Known As
Advent France Biotechnology
Seed 33%
Concentration shown as share of disclosed investments by stage.
